Lactobacillus paracaseiReduces Intestinal Inflammation in Adoptive Transfer Mouse Model of Experimental Colitis
Open Access
- 25 July 2011
- journal article
- research article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2011, 1-13
- https://doi.org/10.1155/2011/807483
Abstract
Studies showed that specific probiotics provide therapeutic benefits in inflammatory bowel disease.In vitroevidence suggested thatLactobacillus paracaseialso called ST11 (CNCM I-2116) is a potent strain with immune modulation properties. However, little is known about its capacity to alleviate inflammatory symptomsin vivoIn this context, the main objective of this study was to investigate the role of ST11 on intestinal inflammation using the adoptive transfer mouse model of experimental colitis. Rag2-/-recipient mice were fed with ST11 (109CFU/day)a month prior toinduce colitis by adoptive transfer of naive T cells. One month later, in clear contrast to nonfed mice, weight loss was significantly reduced by 50% in ST11-fed mice. Further analysis of colon specimens revealed a significant reduction neutrophil infiltration and mucosal expression of IL1β, IL-6, and IL12 proinflammatory cytokines, whereas no consistent differences in expression of antibacterial peptides or tight junction proteins were observed between PBS and ST11-fed mice. All together, our results demonstrate that oral administration of ST11 was safe and had a significant preventive effect on colitis. We conclude that probiotics such asLactobacillus paracaseiharbor worthwhilein vivoimmunomodulatory properties to prevent intestinal inflammation by nutritional approaches.Keywords
This publication has 49 references indexed in Scilit:
- Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitisInflammatory Bowel Diseases, 2011
- A critical role for regulatory T cell–mediated control of inflammation in the absence of commensal microbiotaThe Journal of Experimental Medicine, 2010
- E-Cadherin Marks a Subset of Inflammatory Dendritic Cells that Promote T Cell-Mediated ColitisImmunity, 2010
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- A Novel Probiotic Mixture Exerts a Therapeutic Effect on Experimental Autoimmune Encephalomyelitis Mediated by IL-10 Producing Regulatory T CellsPLOS ONE, 2010
- Generation of regulatory dendritic cells and CD4 + Foxp3 + T cells by probiotics administration suppresses immune disordersProceedings of the National Academy of Sciences of the United States of America, 2010
- Probiotics promote gut health through stimulation of epithelial innate immunityProceedings of the National Academy of Sciences of the United States of America, 2009
- Comparison of the Immunomodulatory Properties of Three Probiotic Strains of Lactobacilli Using Complex Culture Systems: Prediction for In Vivo EfficacyPLOS ONE, 2009
- Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cellsEuropean Journal of Immunology, 2008
- Immunopathogenesis of IBD: insufficient suppressor function in the gut?Gut, 2007